You searched for - Page 64 of 142 - KFF Health News

Pfizer Announces Plans To Invest $5B In U.S. Manufacturing Citing Positive Tax Law Revisions

January 31, 2018 Morning Briefing

The pharmaceutical giant said it will also hand out one-time bonuses this quarter to non-executive employees.

The Next Obamacare Battleground: Subsidies For Out-Of-Pocket Costs

By Ana B. Ibarra March 31, 2017 KFF Health News Original

Exchange enrollees and insurers fret over a lawsuit that could end federal help with copays and deductibles.

La próxima batalla del Obamacare: subsidios para gastos de bolsillo

By Ana B. Ibarra March 31, 2017 KFF Health News Original

Los subsidios que ayudan a las personas con sus copagos y deducibles, distintos a los créditos impositivos para pagar las primas, están en medio de una batalla legal luego de una demanda republicana.

Storm Brewing On Capitol Hill Over Drug Discount Program

December 20, 2017 Morning Briefing

Pharma and hospitals are going head-to-head over cuts to the 340B drug program, which requires pharmaceutical companies to give steep discounts to hospitals and clinics that serve high volumes of low-income patients.

Lawmakers May Reverse ‘Devastating’ Cuts To 340B Drug Program, But There Will Likely Be A Trade-Off

January 11, 2018 Morning Briefing

House Energy and Commerce Committee Chairman Greg Walden (R-Ore.) said his panel is going to be looking at changes Congress can make to the program, which has sparked a furor between the pharmaceutical industry and hospitals. “I think, that we need to bring transparency and accountability to this program for it to survive long term,” Walden said.

Many COPD Patients Struggle To Pay For Each Medicinal Breath

By Sarah Jane Tribble June 5, 2017 KFF Health News Original

One in 9 Medicare enrollees have COPD and many of them can’t afford the inhalers that keep them out of the emergency room.

UnitedHealth Expects $1.7B Windfall From Republicans’ Tax Bill For Next Year

January 17, 2018 Morning Briefing

The country’s largest insurer says it will invest the money in new technology and local community-based health care initiatives.

In Massachusetts, Proposed Medicaid Cuts Put Kids’ Health Care At Risk

By Martha Bebinger, WBUR July 18, 2017 KFF Health News Original

Doctors, consumers and politicians say big federal cuts to Medicaid funding would jeopardize the treatment a lot of kids rely on. The state would either have to make up lost funding or cut benefits.

House’s New ‘Right To Try’ Legislation Ensures FDA’s Oversight Of Terminally Ill Patients Getting Untested Drugs

March 12, 2018 Morning Briefing

The House is expected to vote on the legislation this week. Both the Senate and the president have backed the right-to-try movement in the past. Also on Capitol Hill, the Senate is turning its focus on the contentious debate over the 340B drug discount program, the pharmaceutical industry is trying to get lawmakers to undo a deal that would force drugmakers to pick up more of the tab for prescription spending in the Medicare doughnut hole, and Sen. Claire McCaskill (D-Mo.) wants more donations transparency.

To Help Ward Off Alzheimer’s, Think Before You Eat

By Judith Graham April 6, 2017 KFF Health News Original

Good nutrition has been linked to a boost in senior citizens’ cognitive skills.

Fate Of 340B Drug Discount Program In Spending Bill Pits Hospitals, Pharma

December 14, 2017 Morning Briefing

The 340B program requires drugmakers to offer discounts on medicines sold to safety-net hospitals. Earlier this year, the Trump administration slashed funding for the program, and hospitals want it restored in Congress’ year-end spending bill. Meanwhile, lawmakers are turning their attention to pharmacy benefit managers in their efforts to bring down high drug costs.

By Decade’s End, Calif. Estimates It Would Lose $24B Annually Under GOP Health Plan

By Anna Gorman March 23, 2017 KFF Health News Original

“It’s challenging to see how it would not … jeopardize the entire [Medicaid] program,” a top health official said.

Medicaid Proves A Lifeline For Clients Of Crisis Pregnancy Centers

By Sarah McCammon July 27, 2017 KFF Health News Original

For pregnant women in the United States, Medicaid is less a safety net than a building block of the maternity care system.

Planned Parenthood Funding Could Thwart GOP Efforts On Health Bill

By Julie Rovner May 12, 2017 KFF Health News Original

A provision in the House bill to strip funding from organizations that provide abortions may not meet the strict rules needed to bypass the filibuster in the Senate.

Many Californians Could Be Priced Out Of Exchange Coverage, Analysis Finds

By Ana B. Ibarra March 16, 2017 KFF Health News Original

California’s health insurance exchange released an analysis showing that Republicans’ plan to trim subsidies, on average, by 40% would fall hard on elderly and very low-income people, especially in expensive areas like San Francisco.

On The Air With KHN: What’s Next For The Affordable Care Act?

March 28, 2017 KFF Health News Original

Reporters with Kaiser Health News and California Healthline have appeared on numerous radio and television shows in recent days to assess what’s next for the health law.

Proposed Law Would Require All California Children To Be Screened For Lead

By Ana B. Ibarra March 14, 2017 KFF Health News Original

Under the current statute, kids are tested for lead only if they’re on certain government programs or live in older buildings. That leaves many other California children at risk, lawmaker says.

Groundbreaking Gene Therapy Drastically Reduces Bleeding Episodes In Hemophilia B Patients

December 7, 2017 Morning Briefing

A hemophilia expert called the results “striking” and just another example of a gene therapy renaissance that has brought patients with rare inherited diseases closer to potential cures. In other public health news: exercise and fat; skin cancer; a ketogenic diet; the flu; and more.

In A ‘Shot Across The Bow Of The Bad Guys,’ Hospitals Decide To Try Making Their Own Drugs

January 18, 2018 Morning Briefing

Hospitals have long borne the brunt of price increases in the industry, facing shortages of drugs like morphine or encountering sudden hikes for old, off-patent products. Sick and tired of it, they’re taking measures into their own hands. In other pharmaceutical news: updates on the 340B drug program debate and legislation on over-the-counter drug approvals.

Con el fin de DACA, jóvenes inmigrantes temen por su salud

By Barbara Feder Ostrov and Anna Gorman September 6, 2017 KFF Health News Original

La polémica decisión de la administración Trump de eliminar el programa DACA hace más que poner a casi 800.000 “dreamers” bajo el miedo a la deportación. Amenaza el cuidado de salud de miles de adultos jóvenes.

Filter Results

More From KFF Health News